Blue Barn Wealth’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-3,748
Closed -$208K 123
2025
Q3
$208K Sell
3,748
-1,095
-23% -$64.1K 0.09% 163
2025
Q2
$334K Sell
4,843
-271
-5% -$18.4K 0.16% 95
2025
Q1
$355K Sell
5,114
-1,495
-23% -$123K 0.19% 84
2024
Q4
$569K Buy
6,609
+51
+0.8% +$5.51K 0.3% 55
2024
Q3
$781K Buy
6,558
+123
+2% +$16.4K 0.4% 45
2024
Q2
$919K Buy
6,435
+29
+0.5% +$3.84K 0.51% 37
2024
Q1
$823K Sell
6,406
-299
-4% -$35.6K 0.46% 39
2023
Q4
$694K Sell
6,705
-35
-0.5% -$3.46K 0.41% 39
2023
Q3
$613K Buy
6,740
+1,338
+25% +$118K 0.4% 42
2023
Q2
$437K Sell
5,402
-164
-3% -$13.4K 0.28% 60
2023
Q1
$443K Sell
5,566
-118
-2% -$8.37K 0.27% 66
2022
Q4
$385K Buy
5,684
+1,308
+30% +$76.7K 0.25% 65
2022
Q3
$218K Buy
4,376
+406
+10% +$21.8K 0.16% 104
2022
Q2
$221K Sell
3,970
-622
-14% -$34.5K 0.17% 100
2022
Q1
$255K Buy
4,592
+202
+5% +$10.4K 0.18% 91
2021
Q4
$246K Buy
4,390
+18
+0.4% +$975 0.17% 97
2021
Q3
$210K Buy
+4,372
New +$211K 0.18% 103

Other funds holding NVO

Blue Barn Wealth's NVO Position: Q4 2025 in Review

Blue Barn Wealth sold out of Novo Nordisk (NVO) in Q4 2025, closing a stake of 3,748 shares — an estimated $208K sold.

Blue Barn Wealth first reported a position in NVO in Q3 2021 and held it in 17 quarters. The position peaked at $919K in Q2 2024. 1,413 funds tracked by Wall St. Rank hold NVO as of Q4 2025.

  • Blue Barn Wealth reported no remaining Novo Nordisk position as of Q4 2025 after selling out during the quarter.
  • Blue Barn Wealth sold 3,748 Novo Nordisk shares in Q4 2025, an estimated $208K.
  • Blue Barn Wealth first reported a position in Novo Nordisk in Q3 2021 and held it in 17 quarters.
  • Blue Barn Wealth's Novo Nordisk position peaked at $919K in Q2 2024.
  • 1,413 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.

Based on Blue Barn Wealth's 13F filing for Q4 2025, filed 10 Feb 2026.